❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Annual reports ❭

Annual reports

Download reports in PDF format:

2024 Single page format Double page format  
2023 Single page format Double page format  
2022 Single page format Double page format  
2021 Single page format Double page format  
2020 Single page format Double page format Abstract (in Norwegian)
2019 Single page format Double page format Abstract (in Norwegian)
2018 Single page format Double page format Abstract (in Norwegian)
2017 Single page format Double page format  
2016 Single page format Double page format  
2015 Single page format    
2014 Single page format    

 

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Imaging facilities
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Hurley JH, Coyne AN, Miączyńska M, Stenmark H (2025)
The expanding repertoire of ESCRT functions in cell biology and disease
Nature (in press)
DOI 10.1038/s41586-025-08950-y, PubMed 40562928

Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA (2025)
Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis
J Transl Med, 23 (1), 672
DOI 10.1186/s12967-025-06644-7, PubMed 40528241

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer (in press)
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692

More selected publications

Most recent publications

Pagui ECK, Brant SB, Svendsen K, Frigessi A, Helland Å, Thoresen S, Jonasson C (2025)
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pharmacoepidemiol Drug Saf, 34 (7), e70181
DOI 10.1002/pds.70181, PubMed 40552731

Hurley JH, Coyne AN, Miączyńska M, Stenmark H (2025)
The expanding repertoire of ESCRT functions in cell biology and disease
Nature (in press)
DOI 10.1038/s41586-025-08950-y, PubMed 40562928

Kranjec C, Oftedal TF, Ovchinnikov KV, da Silva Duarte V, Hermansen S, Kaus-Drobek M, Sabała I, Porcellato D, Carlsen H, Kjos M (2025)
An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: in vitro and in vivo assessment of its efficacy
Appl Environ Microbiol, e0243324 (in press)
DOI 10.1128/aem.02433-24, PubMed 40552825

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)